← Eichor
Study identifier: NCT06687291 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer

Condition: Gastroesophageal Cancer (GC) · Postoperative Delirium (POD) · Quality of Life (QOL)  ·  Sponsor: Karolinska Institutet

PhaseN/A
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this observational study is to investigate the incidence of Post Operative Delirium (POD) after gastroesophageal cancer surgery. Secondary objectives are to investigate the relationship between POD, preoperative depression, frailty, quality of life, malnutrition and sarcopenia. Participants identified with POD will be asked (at the routine follow-up meeting after surgery) to participate in an qualitative interview, in order to understand the participant's experience of postoperative delirium. The main objective aims to answer: What is the incidence of POD after gastroesophageal cancer surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Marcus Nömm, PhD-student  ·  0733765652  ·  marcus.nomm@ki.se

Maria Lampi, PhD  ·  0852483721  ·  maria.lampi@ki.se

Always discuss trial participation with your own doctor first.

Locations (1)

Karolinska University Hospital, HuddingeHuddinge, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06687291